VanEck Pharmaceutical ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
PPH price
Table
| Date | PPH close |
|---|---|
| Oct 16, 2026 | $114.41 |
| Oct 19, 2026 | $113.48 |
| Oct 20, 2026 | $116.34 |
| Oct 21, 2026 | $115.58 |
| Oct 22, 2026 | $117.04 |
| Oct 23, 2026 | $114.93 |
| Oct 26, 2026 | $114.79 |
| Oct 27, 2026 | $114.63 |
| Oct 28, 2026 | $114.19 |
| Oct 29, 2026 | $116.92 |
| Oct 30, 2026 | $119.33 |
| Nov 2, 2026 | $119.21 |
| Nov 3, 2026 | $118.60 |
| Nov 4, 2026 | $122.11 |
| Nov 5, 2026 | $119.03 |
| Nov 6, 2026 | $118.83 |
| Nov 9, 2026 | $121.25 |
| Nov 10, 2026 | $121.59 |
| Nov 11, 2026 | $121.71 |
| Nov 12, 2026 | $121.30 |
| Nov 13, 2026 | $122.65 |
| Nov 16, 2026 | $121.59 |
Daily net flows, 1M
Net outflow over the range: −$54M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct 13 | $11M |
| Oct 14 | $16.7M |
| Oct 15 | $5.7M |
| Oct 16 | $28.7M |
| Oct 19 | −$51.2M |
| Oct 20 | $23.1M |
| Oct 21 | −$52M |
| Oct 22 | −$5.8M |
| Oct 23 | $0 |
| Oct 26 | $0 |
| Oct 27 | −$5.7M |
| Oct 28 | −$5.7M |
| Oct 29 | $5.8M |
| Oct 30 | $6M |
| Nov 2 | $35.7M |
| Nov 3 | $0 |
| Nov 4 | $6.1M |
| Nov 5 | −$48.4M |
| Nov 6 | −$17.7M |
| Nov 9 | $0 |
| Nov 10 | −$6.1M |
| Nov 11 | $0 |
| Nov 12 | −$6.1M |
| Nov 13 | $6.1M |
Money is leaving — −$116M in net outflows over the past month, about 10.5% of the fund's asset base, while the price has returned +17.9% so far this year. At 0.36% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 23.05% | $1431.67 | -0.8% | ||
| 2 | MRKMERCK & CO | 12.09% | $144.46 | -2.2% | ||
| 3 | NVONOVO NORDISK A S | 5.49% | $41.60 | -0.1% | ||
| 4 | MCKMCKESSON | 5.00% | $1105.04 | +0.2% | ||
| 5 | PFEPFIZER | 4.67% | $28.86 | -0.1% | ||
| 6 | TEVATEVA PHARMACEUTICAL | 4.77% | $42.57 | -4.3% | ||
| 7 | CORCENCORA INC | 4.49% | $356.94 | -0.6% | ||
| 8 | BMYBRISTOL MYERS SQUIBB | 4.42% | $62.93 | -0.8% | ||
| 9 | GSKGSK | 4.19% | $50.41 | -0.1% | ||
| 10 | ABBVABBVIE | 3.65% | $294.55 | -0.2% | ||
| 11 | AZNASTRAZENECA | 3.65% | $184.02 | -0.2% | ||
| 12 | NVSNOVARTIS AG | 3.63% | $160.20 | -0.2% | ||
| 13 | SNYSANOFI | 3.50% | $48.39 | +0.0% | ||
| 14 | HLNHALEON | 3.36% | $9.20 | +0.3% | ||
| 15 | JNJJOHNSON & JOHNSON | 3.32% | $282.55 | -1.1% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 26Sector weights
- Healthcare100%
- Health Technology86.33%
- Distribution Services13.67%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 86.33% |
| Distribution Services | 13.67% |
Country weights
- United States68.56%
- United Kingdom11.37%
- Ireland5.73%
- Denmark5.42%
- Israel4.59%
- Switzerland3.72%
- France3.53%
- Japan2.81%
Show as table
| Item | Value (%) |
|---|---|
| United States | 68.56% |
| United Kingdom | 11.37% |
| Ireland | 5.73% |
| Denmark | 5.42% |
| Israel | 4.59% |
| Switzerland | 3.72% |
| France | 3.53% |
| Japan | 2.81% |
| 1 week | -0.0% |
| 1 month | +6.3% |
| 3 months | +9.7% |
| 6 months | +20.6% |
| YTD | +17.9% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$6M |
| 1 month | −$116M |
| 3 months | +$32M |
| YTD | −$344M |
| 1 year | −$250M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Dec | $88.8M |
| Jan | −$142.1M |
| Feb | $78.2M |
| Mar | $64.8M |
| Apr | −$295.5M |
| May | −$50.6M |
| Jun | −$100.8M |
| Jul | $37.1M |
| Aug | $85.1M |
| Sep | $22.7M |
| Oct | −$12.3M |
| Nov | −$30.4M |
The top holding is 23.0% of the book; the top ten carry 72%. Spread across 26+ names, it behaves like roughly 11 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $45M |
| JNJ JOHNSON & JOHNSON | $6M | $7M |
| MRK MERCK & CO | $6M | $5M |
| ABBV ABBVIE | $4M | $4M |
| BMY BRISTOL MYERS SQUIBB | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PPH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -33bp on fee · 38× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -33bp on fee · 17× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -31bp on fee · 112× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -32bp on fee · 31× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -32bp on fee · 22× the assets · +$422M in over the month | Head-to-head |


